Iterum Therapeutics (Nasdaq: ITRM) filed a petition in the High Court in Ireland to wind up the company and was placed in provisional liquidation on March 27, 2026.
A court hearing is set for April 13, 2026; Joint Provisional Liquidators from Teneo were appointed to oversee winding down and potential dissolution.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.